Correlation Between Dermata Therapeutics and Soleno Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Soleno Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Soleno Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Soleno Therapeutics, you can compare the effects of market volatilities on Dermata Therapeutics and Soleno Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Soleno Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Soleno Therapeutics.

Diversification Opportunities for Dermata Therapeutics and Soleno Therapeutics

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Dermata and Soleno is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Soleno Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soleno Therapeutics and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Soleno Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soleno Therapeutics has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Soleno Therapeutics go up and down completely randomly.

Pair Corralation between Dermata Therapeutics and Soleno Therapeutics

Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the Soleno Therapeutics. In addition to that, Dermata Therapeutics is 1.2 times more volatile than Soleno Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. Soleno Therapeutics is currently generating about -0.05 per unit of volatility. If you would invest  5,506  in Soleno Therapeutics on September 1, 2024 and sell it today you would lose (235.00) from holding Soleno Therapeutics or give up 4.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Dermata Therapeutics  vs.  Soleno Therapeutics

 Performance 
       Timeline  
Dermata Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dermata Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Soleno Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Soleno Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Soleno Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Dermata Therapeutics and Soleno Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dermata Therapeutics and Soleno Therapeutics

The main advantage of trading using opposite Dermata Therapeutics and Soleno Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Soleno Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will offset losses from the drop in Soleno Therapeutics' long position.
The idea behind Dermata Therapeutics and Soleno Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges